<DOC>
	<DOCNO>NCT00404183</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness ( level pain control ) safety administration Extended Release Hydrocodone/Acetaminophen placebo 5-week dosing period patient osteoarthritis .</brief_summary>
	<brief_title>A Study Comparing Analgesic Efficacy Safety Extended Release Hydrocodone/Acetaminophen ( VicodinÂ® CR ) Placebo Subjects With Osteoarthritis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Hydrocodone</mesh_term>
	<mesh_term>Acetaminophen , hydrocodone drug combination</mesh_term>
	<mesh_term>Oxycodone</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>Males female age 21 75 Has osteoarthritis hip knee Requires therapeutic dos medication osteoarthritis If female , must nonchildbearing potential practice birth control Has sufficient pain justify use roundtheclock opioids Has receive certain type procedure receive certain medication osteoarthritis within specific timeframe Has certain medical condition may interfere pain assessment Is allergic serious reaction hydrocodone , opioids , acetaminophen Has certain infection , injury illness within last month Has major abdominal surgery , certain disease may cause intestinal narrowing , history constipation , diarrhea nausea vomiting Is receive chemotherapy , diagnose certain cancer within past 5 year Has history major psychiatric disorder require treatment certain drug depression Can discontinue pain medication , even short time , prior study start</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Pain associate osteoarthritis</keyword>
</DOC>